Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib and Radiotherapy in Locally Advanced or Recurrent Breast Cancer
NCT01868503Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Jul 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by Stanford University. Started Jul 2013; status: terminated.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01868503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868503.